In other large cohorts where serum biomarkers are routinely used—such as PSA for prostate cancer and CA 15 − 3 or CEA for breast cancer—the added diagnostic value of hPG80 was also evaluated. This evidence concerns the gene KLK3 and Familial prostate cancer.